Old Web
English
Sign In
Acemap
>
authorDetail
>
Margarida L F Martins
Margarida L F Martins
Netherlands Cancer Institute
CYP3A4
Pharmacology
Genetically modified mouse
Oral administration
Chemistry
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
ABCB1 and ABCG2 restrict brain and testis accumulation and, alongside CYP3A, limit oral availability of the novel TRK inhibitor selitrectinib.
2021
Molecular Cancer Therapeutics
Wenlong Li
Rolf W. Sparidans
Margarida L F Martins
Mujtaba El-lari
Maria C. Lebre
Olaf van Tellingen
Jos H. Beijnen
Alfred H. Schinkel
Show All
Source
Cite
Save
Citations (2)
P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib.
2021
Molecular Pharmaceutics
Margarida L F Martins
Nancy H.C. Loos
Sümeyra Mucuk
Danielle de Jong
Maria C. Lebre
Hilde Rosing
Matthijs M. Tibben
Jos H. Beijnen
Alfred H. Schinkel
Show All
Source
Cite
Save
Citations (0)
The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.
2021
Drug and Alcohol Dependence
Margarida L F Martins
Erica A. Wilthagen
Eugenia Oviedo-Joekes
Jos H. Beijnen
Nelda de Grave
Ambros Uchtenhagen
Thilo Beck
Wim van den Brink
Alfred H. Schinkel
Show All
Source
Cite
Save
Citations (1)
1